ASHLEY HOPKINS: Open Payments
NPI 1417239096 · VESTAL, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,591 in 86 payments from 12 companies in 2025. Trend: 2023 $611 · 2024 $1,193 · 2025 $1,591
Food & beverage: $1,581Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $331 |
| Janssen Biotech, Inc. | 18 | $315 |
| UCB, Inc. | 8 | $184 |
| GENZYME CORPORATION | 6 | $136 |
| Galderma Laboratories, L.P. | 9 | $135 |
| Lilly USA, LLC | 7 | $125 |
| Novartis Pharmaceuticals Corporation | 5 | $117 |
| Amgen Inc. | 3 | $80 |
| LEO Pharma Inc. | 3 | $74 |
| E.R. Squibb & Sons, L.L.C. | 2 | $34 |
Products named: TREMFYA, SKYRIZI, Bimzelx, DUPIXENT, NEMLUVIO, TALTZ, Otezla, ADBRY.
Industry payments across NY — which companies pay providers there.
